Copertina

A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine ( TEAM) study

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Gregory A. Panza, Michael A. L. Johnson, Deena E. Kuruvilla
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Effects of fremanezumab on migraine‐associated symptoms and medication use in Japanese and Korean patients with episodic migraine: Exploratory endpoint analysis of a multicenter, randomized, double‐blind, placebo‐controlled trial
di: Muneto Tatsumoto, et al.
Pubblicazione: (2024)

Vaporized cannabis versus placebo for acute migraine: A randomized, double‐blind, placebo‐controlled crossover trial
di: Nathaniel M. Schuster, et al.
Pubblicazione: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Japan: A dose‐ranging, double‐blind, randomized controlled trial
di: Koichi Ikeda, et al.
Pubblicazione: (2025)

TRPM3 activation causes CGRP release in trigeminal neurons: Implications for migraine mechanisms
di: Philip V. Reducha, et al.
Pubblicazione: (2025)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
di: Shuu‐Jiun Wang, et al.
Pubblicazione: (2024)

Partial rebreathing is not effective for early treatment of migraine with aura attacks: Results of a double‐blind, randomized, controlled trial ( PAREMA1 )
di: Charly Gaul, et al.
Pubblicazione: (2025)

Remote electrical neuromodulation for reducing procedural pain in patients with chronic migraine receiving onabotulinumtoxinA injections: A randomized sham‐controlled study
di: Nan Cheng, et al.
Pubblicazione: (2025)

The PATCH trial: 5% lidocaine‐medicated plaster for trigeminal neuralgia—Results of a multicentric, enriched enrollment, randomized withdrawal, double‐blind, vehicle‐controlled, parallel‐group study
di: Chunmei Zhao, et al.
Pubblicazione: (2024)

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
di: Lawrence C. Newman, et al.
Pubblicazione: (2025)

Migraine is a disorder of function: No evidence for structural alterations within the central nervous system in migraine
di: Jan Mehnert, et al.
Pubblicazione: (2025)

Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo‐controlled clinical trials
di: Larry Charleston, et al.
Pubblicazione: (2026)

Transcutaneous electrical nerve stimulation of the occipital nerves as treatment for chronic cluster headache
di: Ida Stisen Fogh‐Andersen, et al.
Pubblicazione: (2024)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
di: Stephen D. Silberstein, et al.
Pubblicazione: (2024)

Remote electrical neuromodulation to treat children and adolescents with migraine in the emergency department: A randomized double‐dummy pilot trial
di: Serena Laura Orr, et al.
Pubblicazione: (2024)

Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents
di: Bilal Ahmed Rizvi, et al.
Pubblicazione: (2024)

Beyond symptom: Exploring the analgesic properties of vomiting in patients with migraine
di: Antonio Munafò, et al.
Pubblicazione: (2026)

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
di: Genaro G. Gutierrez, et al.
Pubblicazione: (2025)

A history of abuse is associated with more severe migraine‐ and pain‐related disability: Results from the American Registry for Migraine Research
di: Meesha Trivedi, et al.
Pubblicazione: (2024)

Long‐term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial
di: Anna Gryglas‐Dworak, et al.
Pubblicazione: (2024)

Regulation of Na+, K+‐ATPase by cardiotonic steroids: Participation in the sodium theory for migraine
di: Roger Gregory Biringer
Pubblicazione: (2025)

Migraine in women
di: Arathi Nandyala, et al.
Pubblicazione: (2024)

Cognitive symptoms in veterans with migraine or traumatic brain injury: A Million Veteran Program study
di: Matthew S. Herbert, et al.
Pubblicazione: (2024)

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing
di: Richard B. Lipton, et al.
Pubblicazione: (2025)

Factors associated with efficacy of occipital nerve stimulation in medically intractable chronic cluster headache
di: Roemer B. Brandt, et al.
Pubblicazione: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
di: Graham A. McLeod, et al.
Pubblicazione: (2025)

The impact of headache intensity on speech in participants with migraine and acute post‐traumatic headache
di: Dani C. Smith, et al.
Pubblicazione: (2024)

Regulation of headache response and transcriptomic network by the trigeminal ganglion clock
di: Chorong Han, et al.
Pubblicazione: (2024)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
di: Christopher C. Anderson, et al.
Pubblicazione: (2024)

Comment on “Second‐line pharmacological treatment strategies for trigeminal neuralgia: A retrospective comparison of lacosamide, gabapentin and baclofen”
di: Alcántara Montero A
Pubblicazione: (2025)

Comparing single‐ and repeat‐dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial
di: Emmanuelle A. D. Schindler, et al.
Pubblicazione: (2025)

A placebo controlled, randomized clinical trial of galcanezumab for vestibular migraine: The INVESTMENT study
di: Jeffrey D. Sharon, et al.
Pubblicazione: (2024)

Depression and anxiety are not associated with migraine outcomes in children and adolescents
di: Amy A. Gelfand
Pubblicazione: (2024)

Temporary occipital nerve stimulation as transitional therapy for chronic intractable cluster headache: A case report and proof of concept
di: Keshet Pardo, et al.
Pubblicazione: (2026)

Eicosapentaenoic acid versus placebo as adjunctive therapy in chronic migraine: A randomized controlled trial
di: Ghader Mohammadnezhad, et al.
Pubblicazione: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
di: Yunus Emre Meydanal, et al.
Pubblicazione: (2025)

The clinical effect of an implanted vagus nerve stimulator in a patient with chronic cluster headache and focal epilepsy – A case report
di: Paulien J. van Tilborg, et al.
Pubblicazione: (2025)

Editorial: Migraine as a marker of maternal morbidity
di: Barlas Benkli
Pubblicazione: (2026)

Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
di: Irina Krikova, et al.
Pubblicazione: (2024)

Neuralgia in the occipital region associated with ipsilateral trigeminal herpes zoster: Three case reports
di: Akihiko Nakaya, et al.
Pubblicazione: (2024)